Journal article Open Access

Molecular targets for AIDS therapy

Mitsuya, H.; Yarchoan, R.; Broder, S.


Citation Style Language JSON Export

{
  "DOI": "10.1126/science.1699273", 
  "author": [
    {
      "family": "Mitsuya, H."
    }, 
    {
      "family": "Yarchoan, R."
    }, 
    {
      "family": "Broder, S."
    }
  ], 
  "issued": {
    "date-parts": [
      [
        1990, 
        9, 
        28
      ]
    ]
  }, 
  "abstract": "The development of antiretroviral therapy against acquired immunodeficiency syndrome (AIDS) has been an intense research effort since the discovery of the causative agent, human immunodeficiency virus (HIV). A large array of drugs and biologic substances can inhibit HIV replication in vitro. Nucleoside analogs--particularly those belonging to the dideoxynucleoside family--can inhibit reverse transcriptase after anabolic phosphorylation. 3'-Azido-2',3'-dideoxythymidine (AZT) was the first such drug tested in individuals with AIDS, and considerable knowledge of structure-activity relations has emerged for this class of drugs. However, virtually every step in the replication of HIV could serve as a target for a new therapeutic intervention. In the future, non-nucleoside-type drugs will likely become more important in the experimental therapy of AIDS, and antiretroviral therapy will exert major effects against the morbidity and mortality caused by HIV.", 
  "title": "Molecular targets for AIDS therapy", 
  "type": "article-journal", 
  "id": "1230944"
}
477
284
views
downloads
Views 477
Downloads 284
Data volume 865.7 MB
Unique views 455
Unique downloads 269

Share

Cite as